Computerized Tomography as First Coronary Study?

According to this new document recently published in JACC, a computerized tomography (CT) coronary angiography should be the first study done to diagnose a stable coronary artery disease.

ffr tomografia

A multidisciplinary group of experts recommends using computerized tomography as first-line diagnosis in stable patients. According to these professionals, guidelines should be updated soon.

Given the accruing evidence favoring anatomical studies (such as the PROMISE, the SCOT-HEART, and, more recently, the ISCHEMIA), this expert committee believes that computerized tomography offers the greatest benefit for patient management.

Despite the evidence supporting the benefits and even the savings in patients without known coronary disease, reality indicates that, for every 60 gamma-camera studies (single photon emission computed tomography, SPECT) only one tomography is conducted.


Read also: Visual Assessment for Non-Culprit Lesion Revascularization.


his could be partially due to the vast number of centers with nuclear medicine and stress echocardiography, the traditional idea that function supersedes anatomy, and the administrative difficulties faced by health systems in the payment of tomographies.

Both United Kingdom and European guidelines have been updated with the use of CT in chronic coronary syndromes, but the old school approach is still going strong in the United States. There might also be a lack of trained staff who can interpret the images.

We might be reaching a time when computerized tomography scans will completely replace us, and we will only enter the cath lab for therapeutic procedures.

Original Title: Current evidence and recommendations for coronary CTA first in evaluation of stable coronary artery disease.

Reference: Poon M et al. J Am Coll Cardiol. 2020;76:1358-1362.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

Bioresorbable devices vs DES in patients at high risk of restenosis. Seven-year follow-up of the COMPARE-ABSORB trial

Studies with second-generation drug-eluting stents (DES) have shown that the rate of target lesion failure (TLF) increases linearly up to 5–10 years of follow-up,...

Sheathless Femoral Impella: A New Strategy to Reduce Vascular Complications in High-Risk PCI?

Patients with complex coronary artery disease or cardiogenic shock undergoing percutaneous coronary intervention (PCI) may benefit from the hemodynamic support provided by percutaneous ventricular...

OCT- and IVUS-Guided Coronary Angioplasty in Acute Coronary Syndrome: Long-Term Clinical Outcomes

Percutaneous coronary angioplasty (PCI) in patients with acute coronary syndrome (ACS) has reduced mortality in the acute phase. However, recurrent ACS and target vessel...

Rolling Stone: Registry of Intravascular Lithotripsy vs Atherectomy Use in Complex Calcified Lesions

Severe coronary calcification represents one of the main challenges in performing percutaneous coronary intervention, both due to the higher risk of stent underexpansion and...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Bioresorbable devices vs DES in patients at high risk of restenosis. Seven-year follow-up of the COMPARE-ABSORB trial

Studies with second-generation drug-eluting stents (DES) have shown that the rate of target lesion failure (TLF) increases linearly up to 5–10 years of follow-up,...

Low-Dose Rivaroxaban After Peripheral Angioplasty: Effectiveness and Safety in Real-World Clinical Practice

Following lower limb revascularization, optimal medical therapy includes antiplatelet agents, high-intensity statins, and control of cardiovascular risk factors. Recent studies such as COMPASS and...

Sheathless Femoral Impella: A New Strategy to Reduce Vascular Complications in High-Risk PCI?

Patients with complex coronary artery disease or cardiogenic shock undergoing percutaneous coronary intervention (PCI) may benefit from the hemodynamic support provided by percutaneous ventricular...